跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TI-4
首页
药物
TI-4
TI-4
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Ti-4 protein derived from Triatoma infestans exhibiting activity to inhibit platelet aggregation
申请人: UNIV MIE
优先权: 2002
US
2 件公开
Highly active, selective, accessible, and robust zeolitic Ti-epoxidation catalyst
申请人: UNIV CALIFORNIA
优先权: 2014
CN
US
2 件公开
Ti-Si molecular sieve catalyst and application
申请人: HENAN QIMINGSHAN CHEMICAL CO LTD
优先权: 2015
CN
Immobilized metal ion affinity chromatography functionalized hybrid monolithic material, and preparation method and application thereof
申请人: DALIAN INST CHEM & PHYSICS CAS
优先权: 2018
CN
一种环己酮双氧水氧化制备ε-己内酯的催化剂及其制备方法与应用
申请人: 华东理工大学
优先权: 2024
CN
Titanium-maltol compound and method of synthesizing the same
申请人: MELENDEZ ENRIQUE
优先权: 2008
US
Method for preparing dexlansoprazole through catalysis of hexadentate ligand
申请人: UNIV CHANGZHOU
优先权: 2020
CN
Au/Ti-S catalyst as well as preparation method and application thereof
申请人: UNIV XIAMEN
优先权: 2020
CN
药物
反馈